Australia markets open in 6 hours 56 minutes

Jack Nathan Medical Corp. (JNHMF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0675-0.0886 (-56.76%)
At close: 09:30AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.1561
Open0.0675
BidN/A x N/A
AskN/A x N/A
Day's range0.0675 - 0.0675
52-week range0.0350 - 0.2890
Volume275
Avg. volume11,417
Market cap8.1M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-0.0770
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Jack Nathan Health to Appoint New Chief Financial Officer

    TORONTO, September 20, 2022--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") announces that David Berman stepped down from his position as Chief Financial Officer of the Company effective as September 19, 2022. "On behalf of myself and the board of directors, we want to thank David for his contributions to Jack Nathan Health. He has been a key contributor to our success to date, and we wish him the best in his future endeavors," said Dr. Glenn C

  • Business Wire

    Jack Nathan Health Announces Its Q1 Fiscal 2023 Financial Results

    TORONTO, June 30, 2022--Jack Nathan Health Announces Q1-Fiscal 2023 Financial Results.

  • Business Wire

    Jack Nathan Health Announces Its Q4 and Year End Fiscal 2022 Financial Results

    TORONTO, June 01, 2022--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") announced today its audited consolidated annual financial results for the fourth quarter of fiscal 2022, and fiscal year ended January 31, 2022. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").